Gyre Therapeutics, Inc. (GYRE) Dividend History

Gyre Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies targeting neurological and neurodegenerative disorders. Utilizing advanced drug delivery platforms, Gyre aims to address unmet medical needs through novel treatments that improve patient outcomes.

12770 High Bluff Drive, Suite 150, San Diego, CA, 92130
Phone: (619) 949-3681
Website: https://www.gyretx.com

Dividend History

Pay Date Amount Ex Dividend Date Record Date
January 12, 2023 $0.24 01/13/2023 01/05/2023
September 20, 2022 $1.43 09/21/2022 09/06/2022
August 19, 2015 $0.57 08/20/2015 08/14/2015

Dividends Summary

  • Gyre Therapeutics, Inc. has issued 3 dividend payments over the past 8 years
  • The most recent dividend was paid 923 days ago, on January 12, 2023
  • The first recorded dividend was paid on August 19, 2015
  • The highest dividend payout was $1.43 per share
  • The average dividend over this 8 year span is $0.75 per share
  • Gyre Therapeutics, Inc. has decreased its dividend payments by 57.84% since 2015

Company News

  • Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China

    Gyre Therapeutics announced the first dosing in a Phase 1 clinical trial of its novel drug F230 for the treatment of pulmonary arterial hypertension (PAH) in China. This milestone marks Gyre's entry into the PAH field, a rare and high-mortality condition with limited treatment options.

    GlobeNewswire Inc.
  • Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents. Fastenal shares dipped 6.7% to $69.73 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Rallybio Corporation (NASDAQ: RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT. Rent the Runway, Inc. (NASDAQ: RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance. Eliem Therapeutics, Inc. (NASDAQ: ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement. Akanda Corp. (NASDAQ: AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry. Alpine Immune Sciences, Inc. (NASDAQ: ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company. Candel Therapeutics, Inc. (NASDAQ: CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof ...

    Benzinga
    Featured Companies: AKAN ANAB APVO CADL CLRO ELVN ENLV ESPR FAST GCT GL GVH JANX KMX LOVE MRIN NRIX NYXH RENT RLYB SPRC STEP SUUN VERB WD WNW
  • Is It Time to Buy the Nasdaq's 5 Worst-Performing Stocks in February 2024?

    Some Nasdaq stocks are soaring in 2024, but these five charts are down by 40% or more. Are any of these struggling stocks actually good buys at a low price?

    The Motley Fool
    Featured Companies: CIFR HUT SGML
Page data last updated 07/23/2025 08:51:09 UTC